| Table 2. Outcomes of ICSI PGT-M cycles | |
| Cases (percentage) | |
|---|---|
| PGT cycles/total ICSI cycles | 528/5,070 (10.4%) |
| PGT-M cycles/PGT cycles | 72/528 (13.6%) |
| PGT-M cycles/total ICSI cycles | 72/5,070 (1.4%) |
| -PGT-M blastocyst biopsy/PGT-M cycles | 7/72 (9.7%) |
| -PGT-M blastocyst biopsy/PGT cycles cycles | 7/528 (1.3%) |
| -PGT-M blastocyst biopsy/total ICSI cycles | 7/5,070 (0.13%) |
| PGT-M embryos biopsied/PGT embryos | 434/2,594 (16.7%) |
| PGT-M embryos biopsied/total ICSI embryos | 434/29,798 (1.5%) |
| PGT-M embryos diagnosed/biopsied | 404/434 (93%) |
| -Normal embryos/diagnosed | 91/404 (22.5%) |
| -Carrier embryos/diagnosed | 149/404 (36.9%) |
| -Affected embryos diagnosed | 164/404 (40.6%) |
| PGT-M Cycles with an embryo to transfer | 49/72 (68.0%) |
| PGT-M Cancellation rate | 23/72 (32.0%) |
| PGT-M Implantation rate (foetal sacs/embryos transferred) | 17/77 (22.1%) |
| PGT-M Pregnancy rate (per embryo transfer) | 14/49 (28.6%) |
| PGT-M Miscarriage rate | 1/14 (7.1%) |
| PGT-M Live birth rate | 13/49 (26.5%) |